InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: Doctor Detroit post# 13201

Tuesday, 06/05/2018 11:06:27 AM

Tuesday, June 05, 2018 11:06:27 AM

Post# of 16886
to shelve it would expose INVVV to the same legal challenges it faces on anti-competition when they stopped manufacturing their oral suboxone pill to favor their film, before generic was available ... I always believed the roll out market for this product should have been to self-funded entities like Kaiser HMO, VA, prison system...no insurance required and medical staff on hand to do procedures... fussing w/individual providers reliant on insurance reimburses & having medical personnel to insert/remove the rods is not profitable for small MAT programs run by one doc who passes out buprenorphine pills and maybe can handle an injection ... all that being said, ALKS already has a relationship w/prison systems as they pushed their vivitrol at the expense of buprenorphine by convincing wardens it was the only "non-narcotic solution"... the ALKS CEO has changed his tune, saying every modality approved by FDA should be available to everyone.... I think ALKS can profit by bringing this probuphine in their fold...not the least of which is they have the capability to manufacture as well as to distribute to a closed system... TTNP's ability to get this off the ground on their own?... market doesn't think so
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News